annual CFO:
$454.60M+$79.66M(+21.25%)Summary
- As of today (September 14, 2025), BIO annual cash flow from operations is $454.60 million, with the most recent change of +$79.66 million (+21.25%) on December 31, 2024.
- During the last 3 years, BIO annual CFO has risen by +$870.04 million (+209.43%).
- BIO annual CFO is now -68.34% below its all-time high of $1.44 billion, reached on December 31, 2022.
Performance
BIO Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$116.50M-$13.40M(-10.32%)Summary
- As of today (September 14, 2025), BIO quarterly cash flow from operations is $116.50 million, with the most recent change of -$13.40 million (-10.32%) on June 30, 2025.
- Over the past year, BIO quarterly CFO has increased by +$18.85 million (+19.31%).
- BIO quarterly CFO is now -91.18% below its all-time high of $1.32 billion, reached on December 31, 2022.
Performance
BIO quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$534.18M+$18.85M(+3.66%)Summary
- As of today (September 14, 2025), BIO TTM cash flow from operations is $534.18 million, with the most recent change of +$18.85 million (+3.66%) on June 30, 2025.
- Over the past year, BIO TTM CFO has increased by +$580.23 million (+1260.07%).
- BIO TTM CFO is now -66.93% below its all-time high of $1.62 billion, reached on September 30, 2023.
Performance
BIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BIO Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +21.3% | +19.3% | +1260.1% |
3 y3 years | +209.4% | -69.9% | -31.6% |
5 y5 years | -0.7% | +167.2% | +2430.8% |
BIO Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -68.3% | +209.4% | -91.2% | +108.6% | -66.9% | +166.8% |
5 y | 5-year | -68.3% | +209.4% | -91.2% | +108.6% | -66.9% | +166.8% |
alltime | all time | -68.3% | +209.4% | -91.2% | +108.6% | -66.9% | +166.8% |
BIO Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $116.50M(-10.3%) | $534.18M(+3.7%) |
Mar 2025 | - | $129.90M(+4.6%) | $515.33M(+13.4%) |
Dec 2024 | $454.60M(+21.2%) | $124.17M(-24.1%) | $454.60M(+10.5%) |
Sep 2024 | - | $163.61M(+67.6%) | $411.48M(-993.6%) |
Jun 2024 | - | $97.65M(+41.2%) | -$46.05M(-113.9%) |
Mar 2024 | - | $69.17M(-14.6%) | $332.16M(-11.4%) |
Dec 2023 | $374.94M(-73.9%) | $81.05M(-127.6%) | $374.94M(-76.8%) |
Sep 2023 | - | -$293.92M(-161.8%) | $1.62B(+189.0%) |
Jun 2023 | - | $475.85M(+325.0%) | $558.92M(+19.0%) |
Mar 2023 | - | $111.96M(-91.5%) | $469.76M(-67.3%) |
Dec 2022 | $1.44B(-445.7%) | $1.32B(-197.9%) | $1.44B(-279.7%) |
Sep 2022 | - | -$1.35B(-449.2%) | -$799.24M(-202.3%) |
Jun 2022 | - | $386.69M(-64.1%) | $781.27M(+42.3%) |
Mar 2022 | - | $1.08B(-218.0%) | $549.21M(-232.2%) |
Dec 2021 | -$415.44M(-172.2%) | -$914.03M(-496.8%) | -$415.44M(-126.4%) |
Sep 2021 | - | $230.36M(+49.0%) | $1.57B(+39.7%) |
Jun 2021 | - | $154.62M(+36.1%) | $1.13B(+41.1%) |
Mar 2021 | - | $113.61M(-89.4%) | $797.93M(+38.7%) |
Dec 2020 | $575.33M(+25.6%) | $1.07B(-595.2%) | $575.33M(-269.4%) |
Sep 2020 | - | -$217.04M(+25.1%) | -$339.70M(+1382.3%) |
Jun 2020 | - | -$173.48M(+59.2%) | -$22.92M(-107.5%) |
Mar 2020 | - | -$108.99M(-168.2%) | $305.96M(-33.2%) |
Dec 2019 | $457.90M(+60.4%) | $159.80M(+60.2%) | $457.90M(+13.6%) |
Sep 2019 | - | $99.75M(-35.8%) | $403.10M(+10.2%) |
Jun 2019 | - | $155.40M(+261.9%) | $365.63M(+26.9%) |
Mar 2019 | - | $42.94M(-59.1%) | $288.09M(+0.9%) |
Dec 2018 | $285.49M(+174.2%) | $105.01M(+68.6%) | $285.49M(+14.3%) |
Sep 2018 | - | $62.28M(-20.0%) | $249.85M(+15.6%) |
Jun 2018 | - | $77.86M(+93.0%) | $216.05M(+7.7%) |
Mar 2018 | - | $40.35M(-41.8%) | $200.69M(+92.7%) |
Dec 2017 | $104.14M(-51.9%) | $69.36M(+143.6%) | $104.14M(-19.8%) |
Sep 2017 | - | $28.48M(-54.4%) | $129.89M(-15.1%) |
Jun 2017 | - | $62.50M(-211.2%) | $153.02M(-8.7%) |
Mar 2017 | - | -$56.20M(-159.1%) | $167.68M(-22.5%) |
Dec 2016 | $216.43M(+16.2%) | $95.12M(+84.3%) | $216.43M(+37.6%) |
Sep 2016 | - | $51.61M(-33.1%) | $157.27M(-16.3%) |
Jun 2016 | - | $77.16M(-1135.9%) | $187.94M(+25.9%) |
Mar 2016 | - | -$7.45M(-120.7%) | $149.32M(-19.8%) |
Dec 2015 | $186.21M(-31.9%) | $35.95M(-56.3%) | $186.21M(-2.5%) |
Sep 2015 | - | $82.28M(+113.5%) | $191.00M(-0.2%) |
Jun 2015 | - | $38.53M(+30.9%) | $191.47M(-18.1%) |
Mar 2015 | - | $29.45M(-27.7%) | $233.84M(-14.4%) |
Dec 2014 | $273.31M(+55.8%) | $40.74M(-50.8%) | $273.31M(-10.7%) |
Sep 2014 | - | $82.75M(+2.3%) | $306.01M(+7.0%) |
Jun 2014 | - | $80.90M(+17.4%) | $286.11M(+27.8%) |
Mar 2014 | - | $68.92M(-6.2%) | $223.90M(+27.6%) |
Dec 2013 | $175.48M(-37.1%) | $73.44M(+16.9%) | $175.48M(-12.6%) |
Sep 2013 | - | $62.85M(+236.3%) | $200.69M(-4.1%) |
Jun 2013 | - | $18.69M(-8.8%) | $209.18M(-20.8%) |
Mar 2013 | - | $20.50M(-79.2%) | $264.14M(-5.3%) |
Dec 2012 | $278.90M(+7.3%) | $98.65M(+38.3%) | $278.90M(+7.8%) |
Sep 2012 | - | $71.34M(-3.1%) | $258.82M(+8.5%) |
Jun 2012 | - | $73.64M(+108.9%) | $238.64M(-13.3%) |
Mar 2012 | - | $35.26M(-55.1%) | $275.29M(+6.0%) |
Dec 2011 | $259.82M(+15.0%) | $78.58M(+53.6%) | $259.82M(-7.7%) |
Sep 2011 | - | $51.16M(-53.6%) | $281.63M(-5.3%) |
Jun 2011 | - | $110.30M(+457.6%) | $297.33M(+33.1%) |
Mar 2011 | - | $19.78M(-80.3%) | $223.42M(-1.1%) |
Dec 2010 | $225.91M(-30.5%) | $100.39M(+50.1%) | $225.91M(-6.4%) |
Sep 2010 | - | $66.87M(+83.8%) | $241.24M(-11.3%) |
Jun 2010 | - | $36.39M(+63.4%) | $271.87M(-20.3%) |
Mar 2010 | - | $22.27M(-80.8%) | $340.97M(+4.9%) |
Dec 2009 | $325.07M(+69.9%) | $115.72M(+18.7%) | $325.07M(+13.0%) |
Sep 2009 | - | $97.49M(-7.6%) | $287.69M(+21.7%) |
Jun 2009 | - | $105.49M(+1555.8%) | $236.32M(+18.2%) |
Mar 2009 | - | $6.37M(-91.9%) | $199.92M(+4.5%) |
Dec 2008 | $191.37M(-0.1%) | $78.34M(+69.9%) | $191.37M(-11.5%) |
Sep 2008 | - | $46.12M(-33.2%) | $216.18M(-3.9%) |
Jun 2008 | - | $69.09M(-3273.5%) | $225.06M(+11.4%) |
Mar 2008 | - | -$2.18M(-102.1%) | $202.04M(+5.5%) |
Dec 2007 | $191.58M | $103.15M(+87.6%) | $191.58M(+33.7%) |
Sep 2007 | - | $55.00M(+19.4%) | $143.26M(+2.2%) |
Jun 2007 | - | $46.07M(-464.5%) | $140.14M(-5.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | -$12.64M(-123.1%) | $147.63M(+24.9%) |
Dec 2006 | $118.20M(+9.2%) | $54.83M(+5.7%) | $118.20M(+4.8%) |
Sep 2006 | - | $51.87M(-3.2%) | $112.76M(+22.6%) |
Jun 2006 | - | $53.56M(-227.3%) | $91.96M(+122.5%) |
Mar 2006 | - | -$42.07M(-185.2%) | $41.33M(-61.8%) |
Dec 2005 | $108.28M(-12.0%) | $49.39M(+59.0%) | $108.28M(-1.5%) |
Sep 2005 | - | $31.07M(+958.7%) | $109.92M(+6.3%) |
Jun 2005 | - | $2.94M(-88.2%) | $103.37M(-14.3%) |
Mar 2005 | - | $24.88M(-51.2%) | $120.67M(-2.0%) |
Dec 2004 | $123.09M(-3.6%) | $51.03M(+108.1%) | $123.09M(+11.8%) |
Sep 2004 | - | $24.52M(+21.2%) | $110.14M(-14.4%) |
Jun 2004 | - | $20.24M(-25.9%) | $128.59M(-3.5%) |
Mar 2004 | - | $27.31M(-28.3%) | $133.23M(+4.4%) |
Dec 2003 | $127.64M(+21.8%) | $38.08M(-11.4%) | $127.64M(+2.8%) |
Sep 2003 | - | $42.97M(+72.8%) | $124.21M(+9.5%) |
Jun 2003 | - | $24.87M(+14.5%) | $113.42M(+4.6%) |
Mar 2003 | - | $21.72M(-37.3%) | $108.38M(+3.4%) |
Dec 2002 | $104.80M(+5.3%) | $34.65M(+7.7%) | $104.80M(-5.2%) |
Sep 2002 | - | $32.18M(+62.2%) | $110.57M(+10.0%) |
Jun 2002 | - | $19.83M(+9.4%) | $100.47M(-13.0%) |
Mar 2002 | - | $18.14M(-55.1%) | $115.42M(+16.0%) |
Dec 2001 | $99.50M(+310.4%) | $40.42M(+83.0%) | $99.50M(+53.2%) |
Sep 2001 | - | $22.08M(-36.5%) | $64.97M(+31.8%) |
Jun 2001 | - | $34.78M(+1470.4%) | $49.28M(+52.6%) |
Mar 2001 | - | $2.21M(-62.3%) | $32.28M(+33.1%) |
Dec 2000 | $24.25M(-46.1%) | $5.88M(-8.1%) | $24.25M(-40.0%) |
Sep 2000 | - | $6.40M(-64.0%) | $40.43M(-7.8%) |
Jun 2000 | - | $17.79M(-405.5%) | $43.84M(+16.1%) |
Mar 2000 | - | -$5.82M(-126.4%) | $37.75M(-16.1%) |
Dec 1999 | $44.98M(+64.6%) | $22.07M(+125.1%) | $44.98M(+30.8%) |
Sep 1999 | - | $9.80M(-16.2%) | $34.39M(+4.0%) |
Jun 1999 | - | $11.70M(+733.0%) | $33.06M(+14.7%) |
Mar 1999 | - | $1.41M(-87.8%) | $28.83M(+5.5%) |
Dec 1998 | $27.34M(+29.5%) | $11.47M(+35.4%) | $27.34M(+33.6%) |
Sep 1998 | - | $8.47M(+13.4%) | $20.46M(-6.6%) |
Jun 1998 | - | $7.47M(-8594.3%) | $21.91M(+0.9%) |
Mar 1998 | - | -$88.00K(-101.9%) | $21.72M(+2.9%) |
Dec 1997 | $21.11M(-36.3%) | $4.60M(-53.7%) | $21.11M(-15.5%) |
Sep 1997 | - | $9.92M(+36.2%) | $24.99M(+51.8%) |
Jun 1997 | - | $7.29M(-1138.3%) | $16.47M(-31.6%) |
Mar 1997 | - | -$702.00K(-108.3%) | $24.08M(-27.4%) |
Dec 1996 | $33.15M(-13.3%) | $8.48M(+505.9%) | $33.18M(-16.2%) |
Sep 1996 | - | $1.40M(-90.6%) | $39.60M(-8.8%) |
Jun 1996 | - | $14.90M(+77.4%) | $43.40M(+13.9%) |
Mar 1996 | - | $8.40M(-43.6%) | $38.10M(-0.3%) |
Dec 1995 | $38.23M(-20.8%) | $14.90M(+186.5%) | $38.20M(+9.8%) |
Sep 1995 | - | $5.20M(-45.8%) | $34.80M(-6.2%) |
Jun 1995 | - | $9.60M(+12.9%) | $37.10M(-11.2%) |
Mar 1995 | - | $8.50M(-26.1%) | $41.80M(-13.5%) |
Dec 1994 | $48.27M(+114.3%) | $11.50M(+53.3%) | $48.30M(-15.9%) |
Sep 1994 | - | $7.50M(-47.6%) | $57.40M(+5.1%) |
Jun 1994 | - | $14.30M(-4.7%) | $54.60M(+37.9%) |
Mar 1994 | - | $15.00M(-27.2%) | $39.60M(+76.0%) |
Dec 1993 | $22.53M(+468.1%) | $20.60M(+338.3%) | $22.50M(-355.7%) |
Sep 1993 | - | $4.70M(-771.4%) | -$8.80M(-269.2%) |
Jun 1993 | - | -$700.00K(-66.7%) | $5.20M(+23.8%) |
Mar 1993 | - | -$2.10M(-80.4%) | $4.20M(+5.0%) |
Dec 1992 | $3.96M(-4.1%) | -$10.70M(-157.2%) | $4.00M(-81.6%) |
Sep 1992 | - | $18.70M(-1200.0%) | $21.70M(+933.3%) |
Jun 1992 | - | -$1.70M(-26.1%) | $2.10M(-63.2%) |
Mar 1992 | - | -$2.30M(-132.9%) | $5.70M(+39.0%) |
Dec 1991 | $4.14M(-65.8%) | $7.00M(-877.8%) | $4.10M(-1466.7%) |
Sep 1991 | - | -$900.00K(-147.4%) | -$300.00K(-105.9%) |
Jun 1991 | - | $1.90M(-148.7%) | $5.10M(+34.2%) |
Mar 1991 | - | -$3.90M(-250.0%) | $3.80M(-68.6%) |
Dec 1990 | $12.09M(+39.8%) | $2.60M(-42.2%) | $12.10M(+27.4%) |
Sep 1990 | - | $4.50M(+650.0%) | $9.50M(+90.0%) |
Jun 1990 | - | $600.00K(-86.4%) | $5.00M(+13.6%) |
Mar 1990 | - | $4.40M | $4.40M |
Dec 1988 | $8.64M(-242.6%) | - | - |
Dec 1987 | -$6.06M(-200.0%) | - | - |
Dec 1986 | $6.07M(+96.2%) | - | - |
Dec 1985 | $3.09M(-222.6%) | - | - |
Dec 1984 | -$2.52M | - | - |
FAQ
- What is Bio-Rad Laboratories, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. annual CFO year-on-year change?
- What is Bio-Rad Laboratories, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. quarterly CFO year-on-year change?
- What is Bio-Rad Laboratories, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. TTM CFO year-on-year change?
What is Bio-Rad Laboratories, Inc. annual cash flow from operations?
The current annual CFO of BIO is $454.60M
What is the all time high annual CFO for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high annual cash flow from operations is $1.44B
What is Bio-Rad Laboratories, Inc. annual CFO year-on-year change?
Over the past year, BIO annual cash flow from operations has changed by +$79.66M (+21.25%)
What is Bio-Rad Laboratories, Inc. quarterly cash flow from operations?
The current quarterly CFO of BIO is $116.50M
What is the all time high quarterly CFO for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high quarterly cash flow from operations is $1.32B
What is Bio-Rad Laboratories, Inc. quarterly CFO year-on-year change?
Over the past year, BIO quarterly cash flow from operations has changed by +$18.85M (+19.31%)
What is Bio-Rad Laboratories, Inc. TTM cash flow from operations?
The current TTM CFO of BIO is $534.18M
What is the all time high TTM CFO for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high TTM cash flow from operations is $1.62B
What is Bio-Rad Laboratories, Inc. TTM CFO year-on-year change?
Over the past year, BIO TTM cash flow from operations has changed by +$580.23M (+1260.07%)